CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Modifiable lifestyle factors and heart failure: A Mendelian randomization study Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Heart Failure and Atrial Fibrillation, Like Fire and Fury Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
|<<... 7 8 9 10 11 12 13 ...>>|

Clinical TrialDecember 8, 2020 Vol 142, Issue 23

JOURNAL：Circulation. Article Link

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

F Cosentino , CP Cannon , DZI Cherney et al. Keywords: ertugliflozin;T2DM; ASCVD, HF

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top